Literature DB >> 19296473

Gaucher disease: resetting the clinical and scientific agenda.

Pramod K Mistry, Neal J Weinreb, Roscoe O Brady, Gregory A Grabowski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19296473      PMCID： PMC2999876          DOI： 10.1002/ajh.21384

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  28 in total

1.  Pulmonary hypertension and Gaucher's disease: logical association or mere coincidence?

Authors:  N D Theise; P C Ursell
Journal:  Am J Pediatr Hematol Oncol       Date:  1990

2.  Gaucher disease, a paradigm for single gene defects.

Authors:  E Beutler
Journal:  Experientia       Date:  1995-03-15

3.  Gaucher's disease of the lung causing severe pulmonary hypertension with associated acute recurrent pericarditis.

Authors:  W C Roberts; D S Fredrickson
Journal:  Circulation       Date:  1967-04       Impact factor: 29.690

Review 4.  Gaucher disease: a century of delineation and understanding.

Authors:  R J Desnick
Journal:  Prog Clin Biol Res       Date:  1982

5.  Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease.

Authors:  N W Barton; R O Brady; J M Dambrosia; A M Di Bisceglie; S H Doppelt; S C Hill; H J Mankin; G J Murray; R I Parker; C E Argoff
Journal:  N Engl J Med       Date:  1991-05-23       Impact factor: 91.245

6.  Low HDL cholesterol levels in type I Gaucher disease do not lead to an increased risk of cardiovascular disease.

Authors:  M de Fost; M Langeveld; R Franssen; B A Hutten; J E M Groener; E de Groot; M M Mannens; H Bikker; J M F G Aerts; J J P Kastelein; C E M Hollak
Journal:  Atherosclerosis       Date:  2008-09-02       Impact factor: 5.162

7.  Pulmonary hypertension in type 1 Gaucher's disease: genetic and epigenetic determinants of phenotype and response to therapy.

Authors:  Pramod K Mistry; Sandra Sirrs; Alicia Chan; Mark R Pritzker; Thomas P Duffy; Marie E Grace; David P Meeker; Martin E Goldman
Journal:  Mol Genet Metab       Date:  2002 Sep-Oct       Impact factor: 4.797

8.  Unusual cardiac, renal and pulmonary involvement in Gaucher's disease. Intersitial glucocerebroside accumulation, pulmonary hypertension and fatal bone marrow embolization.

Authors:  R L Smith; G M Hutchins; G H Sack; R L Ridolfi
Journal:  Am J Med       Date:  1978-08       Impact factor: 4.965

9.  The pathology of Gaucher disease.

Authors:  R E Lee
Journal:  Prog Clin Biol Res       Date:  1982

10.  Increased risk of cancer in patients with Gaucher disease.

Authors:  A Shiran; B Brenner; A Laor; I Tatarsky
Journal:  Cancer       Date:  1993-07-01       Impact factor: 6.860
View more
  9 in total

1.  Expanding spectrum of the association between Type 1 Gaucher disease and cancers: a series of patients with up to 3 sequential cancers of multiple types--correlation with genotype and phenotype.

Authors:  Sarah M Lo; Philip Stein; Sean Mullaly; Michael Bar; Dhanpat Jain; Gregory M Pastores; Pramod K Mistry
Journal:  Am J Hematol       Date:  2010-05       Impact factor: 10.047

Review 2.  Lysosomal enzyme replacement therapies: Historical development, clinical outcomes, and future perspectives.

Authors:  Melani Solomon; Silvia Muro
Journal:  Adv Drug Deliv Rev       Date:  2017-05-11       Impact factor: 15.470

3.  Phenotype diversity in type 1 Gaucher disease: discovering the genetic basis of Gaucher disease/hematologic malignancy phenotype by individual genome analysis.

Authors:  Sarah M Lo; Murim Choi; Jun Liu; Dhanpat Jain; Rolf G Boot; Wouter W Kallemeijn; Johannes M F G Aerts; Farzana Pashankar; Gary M Kupfer; Shrikant Mane; Richard P Lifton; Pramod K Mistry
Journal:  Blood       Date:  2012-04-04       Impact factor: 22.113

Review 4.  The design and clinical development of inhibitors of glycosphingolipid synthesis: will invention be the mother of necessity?

Authors:  James A Shayman
Journal:  Trans Am Clin Climatol Assoc       Date:  2013

Review 5.  Gaucher disease and malignancy: a model for cancer pathogenesis in an inborn error of metabolism.

Authors:  Pramod K Mistry; Tamar Taddei; Stephan vom Dahl; Barry E Rosenbloom
Journal:  Crit Rev Oncog       Date:  2013

Review 6.  Gaucher's disease and cancer: a sphingolipid perspective.

Authors:  Brian M Barth; Sriram S Shanmugavelandy; Diana M Tacelosky; Mark Kester; Samy A F Morad; Myles C Cabot
Journal:  Crit Rev Oncog       Date:  2013

7.  Gaucher disease and cancer: concept and controversy.

Authors:  Francis Y M Choy; Tessa N Campbell
Journal:  Int J Cell Biol       Date:  2011-06-07

8.  Long Term Follow-Up of 103 Untreated Adult Patients with Type 1 Gaucher Disease.

Authors:  Tama Dinur; Ari Zimran; Michal Becker-Cohen; David Arkadir; Claudia Cozma; Marina Hovakimyan; Sebastian Oppermann; Laura Demuth; Arndt Rolfs; Shoshana Revel-Vilk
Journal:  J Clin Med       Date:  2019-10-11       Impact factor: 4.241

Review 9.  Imiglucerase in the treatment of Gaucher disease: a history and perspective.

Authors:  Patrick B Deegan; Timothy M Cox
Journal:  Drug Des Devel Ther       Date:  2012-04-18       Impact factor: 4.162
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.